AI & Emerging Technology

Malaysia's largest telco, CelcomDigi, launches a unified distribution system for its 20M+ users, aiming to streamline sales and enhance partner collaboration.

Celanese completes a key divestiture to tackle its massive debt, while buyer Element Solutions bolsters its high-growth electronics portfolio.

Bolstered by a massive capital infusion and strong investor demand, Vaxcyte is set to accelerate its broad-spectrum vaccine pipeline against market leaders.

Bermuda insurer Relm adds C-suite leaders from AXIS and Zurich, signaling a strategic push to dominate insurance for AI, crypto, and space tech.

JScreen, Manischewitz, and advocate Gila Pfeffer offer low-cost cancer and carrier genetic tests in NYC, transforming community health access.

The University of Arizona's Eller College secures top spots in U.S. News rankings, validating its innovative, flexible online business programs.

Commvault's new solution addresses rising global demand for data control, helping organizations navigate complex regulations without sacrificing cyber resilience.

The Spanish biotech firm strengthens its IP for a novel aggression treatment, targeting a growing multi-billion dollar Japanese CNS market.

As CFO Scott Ullem preps for a key presentation, Edwards balances record innovation and strong financials against new regulatory hurdles. What's at stake?

New data shows traveling to the Bay Area for the 2026 championship is far cheaper than last year, but local prices are still soaring for the big game.

With its stock under pressure, Insperity's upcoming Q4 earnings and 2026 outlook will be a critical test of its strategy to combat rising healthcare costs.

After a regulatory setback, Ultragenyx has resubmitted its BLA for UX111, a potential first-ever treatment for the devastating Sanfilippo syndrome type A.

With national security clearance secured, silicon carbide leader Wolfspeed completes its restructuring, forging a powerful alliance with Japan's Renesas.

COSRX makes history as the official hair sponsor for MISS SOHEE, marking a major milestone for K-beauty in the exclusive world of haute couture.

The 140-year-old industrial giant earns a coveted spot on Fortune's list, recognized for its innovation in smart buildings and sustainability leadership.

CIRM's new RAPID program aims to revolutionize genetic therapy, using scalable platforms to bring hope to millions with rare diseases who have no options.

With stronger Phase 2 data for its ATH434 drug and a healthy cash reserve, Alterity Therapeutics is preparing for a pivotal trial and seeking partners.

ADATA's new $10M investment values publisher 4Divinity at $250M, fueling a global push and a bold new strategy merging game IP with custom hardware.

A strategic merger combines a century of power engineering with modern controls, creating a new force for data centers and telecom infrastructure.

The O.H.I.O. Fund hits major milestones, luring a California construction-tech firm to Columbus and signaling a new era of industrial innovation.